Actualizado Reviewed

Appendix B: Acronyms

Study and Trial Names
AcronymName
ACTGAIDS Clinical Trials Group
AMPAdolescent Master Protocol 
ANRSNational Agency for AIDS Research (France)
ARROWAntiRetroviral Research fOr Watoto
ATHENAAIDS Therapy Evaluation in the Netherlands
ATLASAntiretroviral Therapy as Long-Acting Suppression
BANBreastfeeding, Antiretrovirals, and Nutrition
CHAPASChildren with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens
CHERChildren with HIV Early Antiretroviral Therapy
DolPHIN-2Dolutegravir in Pregnant HIV Mothers and Their Neonates
ECHOEvidence for Contraceptive Options and HIV Outcomes
ENCOREEvaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
EPIICALEarly-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies
EPPICCEuropean Pregnancy and Paediatric Infections Cohort Collaboration
FLAIRFirst Long-Acting Injectable Regimen
HPTNHIV Prevention Trials Network
IeDEAInternational Epidemiology Databases to Evaluate AIDS
IMPAACTInternational Maternal Pediatric Adolescent AIDS Clinical Trials
LATTITUDELong-Acting Therapy to Improve Treatment Success in Daily LifE
MOCHAMore Options for Children and Adolescents
NADIANucleosides And Darunavir/Dolutegravir in Africa
NEVERESTNevirapine Resistance Study
ODYSSEYOnce-daily DTG based ART in Young people vS Standard thErapY
PACTGPediatric AIDS Clinical Trials Group
PAINTPediatric Study in Adolescents Investigating a New NNRTI TMC278
PENPACTTrial run in collaboration between PENTA and PACTG/IMPAACT
PENTAPaediatric European Network for Treatment of AIDS
PHACSPediatric HIV/AIDS Cohort Study
PIANOPaediatric study of Intelence As an NNRTI Option
PREDICTEarly Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV
PROMISEPromoting Maternal and Infant Survival Everywhere Study
PROMOTEPEPFAR PROMise Ongoing Treatment Evaluation
SBIRTScreening, Brief Intervention, and Referral to Treatment
SMILEStrategy for Maintenance of HIV Suppression with Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children
STARTStrategic Timing of AntiRetroviral Treatment
SWORD-1 and SWORD-2Regimen Switch to Dolutegravir + Rilpivirine from Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults

Appendix B: Acronyms

Study and Trial Names
AcronymName
ACTGAIDS Clinical Trials Group
AMPAdolescent Master Protocol 
ANRSNational Agency for AIDS Research (France)
ARROWAntiRetroviral Research fOr Watoto
ATHENAAIDS Therapy Evaluation in the Netherlands
ATLASAntiretroviral Therapy as Long-Acting Suppression
BANBreastfeeding, Antiretrovirals, and Nutrition
CHAPASChildren with HIV in Africa—Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens
CHERChildren with HIV Early Antiretroviral Therapy
DolPHIN-2Dolutegravir in Pregnant HIV Mothers and Their Neonates
ECHOEvidence for Contraceptive Options and HIV Outcomes
ENCOREEvaluation of Novel Concepts in Optimization of antiRetroviral Efficacy
EPIICALEarly-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies
EPPICCEuropean Pregnancy and Paediatric Infections Cohort Collaboration
FLAIRFirst Long-Acting Injectable Regimen
HPTNHIV Prevention Trials Network
IeDEAInternational Epidemiology Databases to Evaluate AIDS
IMPAACTInternational Maternal Pediatric Adolescent AIDS Clinical Trials
LATTITUDELong-Acting Therapy to Improve Treatment Success in Daily LifE
MOCHAMore Options for Children and Adolescents
NADIANucleosides And Darunavir/Dolutegravir in Africa
NEVERESTNevirapine Resistance Study
ODYSSEYOnce-daily DTG based ART in Young people vS Standard thErapY
PACTGPediatric AIDS Clinical Trials Group
PAINTPediatric Study in Adolescents Investigating a New NNRTI TMC278
PENPACTTrial run in collaboration between PENTA and PACTG/IMPAACT
PENTAPaediatric European Network for Treatment of AIDS
PHACSPediatric HIV/AIDS Cohort Study
PIANOPaediatric study of Intelence As an NNRTI Option
PREDICTEarly Versus Deferred Antiretroviral Therapy for Children Older Than 1 Year Infected with HIV
PROMISEPromoting Maternal and Infant Survival Everywhere Study
PROMOTEPEPFAR PROMise Ongoing Treatment Evaluation
SBIRTScreening, Brief Intervention, and Referral to Treatment
SMILEStrategy for Maintenance of HIV Suppression with Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children
STARTStrategic Timing of AntiRetroviral Treatment
SWORD-1 and SWORD-2Regimen Switch to Dolutegravir + Rilpivirine from Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults

Download Guidelines